The conversation about antibiotic stockpiling in prepper media typically treats nonprescription antibiotic use as a future hypothetical — what the operator might do if licensed pharmaceutical supply collapses. The published epidemiology says otherwise. Grigoryan and colleagues' 2019 scoping review in the Annals of Internal Medicine mapped 31 U.S. studies and documented that between 1 and 66 percent of surveyed populations have already used antibiotics without a prescription, that 14 to 48 percent have stored antibiotics for future undirected use, and that 25 percent of primary-care patients in one large study intended to use nonprescription antibiotics. This is not a hypothetical. It is current, prevalent practice — with documented source channels, documented driver variables, and documented public-health consequences. The operator who understands the epidemiology is in a different doctrinal position from the one who treats the question as a thought experiment.

This is Field Brief 08, the closing brief of MED-TAC's Prepper & Survival Med series. It builds on Field Brief 01 (operator-grade antibiotic doctrine via licensed prescriber), Field Brief 03 (the regulatory collapse of the fish-antibiotic supply channel), and Field Brief 04 (medicine cabinet hoarding patterns) by addressing the population-level data the operator needs to make sense of the practice landscape and the public-health context their stockpiling decisions sit inside.

Section 01What Grigoryan 2019 Found

The Grigoryan scoping review screened 17,422 articles and included 31 studies that documented nonprescription antibiotic use in U.S. populations between 2000 and 2019. The studies organized into four population categories: general and pediatric populations surveyed outside healthcare settings; primary care and emergency department patients surveyed within healthcare settings; Hispanic and Latino populations; and injection drug users.

Headline prevalence findings

• General population: 3 to 48 percent reported nonprescription antibiotic use, with the wide range reflecting heterogeneous study methods and population demographics. The 3 percent estimate came from a 2002 survey of parents of young children in Wisconsin and Minnesota; the 48 percent estimate came from a 2018 national internet survey of parents on pediatric antibiotic diversion, in which 48 percent of parents reported saving leftover antibiotics and 73 percent of those parents subsequently diverted those antibiotics to children's siblings, unrelated children, and adults.
• Healthcare-setting patients: 1 to 25 percent. The lowest estimate came from an urban adult population at a Philadelphia medical center; the highest came from a 2016 Texas primary care population in which 25 percent of patients reported nonprescription antimicrobial use in the previous 12 months and an additional 25 percent reported intent to use antibiotics without a prescription.
• Hispanic/Latino populations: 19 to 66 percent. The lowest estimate came from a 2005 South Carolina clinic-based survey; the highest came from a 2014 survey of Latino migrant workers in south Florida.
• Injection drug users: 5 to 32 percent, with all studies focused specifically on self-treatment of abscesses and injection-related wounds with antibiotics obtained on the street.

Storage and intent findings

Storage of antibiotics for possible future use was documented in 14 to 48 percent of surveyed populations. Intent to use stored or otherwise-obtained antibiotics without medical guidance was measured in only one study and found at 25 percent. The combination of measured storage and measured intent suggests that the gap between potential and actual practice is small — many of those who store antibiotics will use them.

What this means for the doctrinal landscape

The numbers reframe the operator-grade antibiotic question. The household stockpile is not happening in a vacuum; it is happening in a country where between a tenth and two-thirds of the relevant population (depending on subgroup) is already doing some version of this. The public-health concerns — antimicrobial resistance, masked infections, adverse drug reactions — are not abstract risks waiting to materialize in some future scenario. They are current realities being generated continuously by current practice. The operator-grade case for licensed prescriber sourcing rests partly on this: the practice that already drives the resistance problem is exactly the practice the operator should not be replicating.

Section 02The Documented Source Channels

Grigoryan and colleagues identified six channels through which nonprescription antibiotics reached U.S. populations. Each has implications for the operator-grade doctrine.

Channel 1: Leftover antibiotics from prior prescriptions (9 studies, ~22,500 respondents)

The single most documented source. Patients who fail to complete their prescribed antibiotic course retain the remaining pills and use them — or share them with household members and acquaintances — when new symptoms appear. The 2018 national parent survey documented this directly: 48 percent of parents saved leftover antibiotics; 73 percent of those parents subsequently diverted them. The 2016 Texas primary-care population reported similar leftover-stockpile patterns.

The mechanism is straightforward and predictable. A patient prescribed a 10-day course discontinues at day 5 or 6 when symptoms resolve. The remaining pills go in the medicine cabinet. When the next sore throat or earache appears, the patient reasons that the medication "worked before" and uses what is on hand rather than scheduling a clinical visit. The same medication may be given to a child or a spouse with apparently similar symptoms. From a public-health perspective, this is a primary driver of subtherapeutic dosing — and subtherapeutic dosing is the textbook condition for selecting antibiotic-resistant bacterial populations.

Channel 2: Family or friend diversion (10 studies, ~22,400 respondents)

The same antibiotic supply, transferred across persons. A parent's leftover course given to a child. A spouse's medication shared. A friend's "extras" passed along when a colleague mentions feeling sick. Grigoryan documents this as the most-frequently-reported sharing pattern in the U.S. data and parallels findings in international literature.

The pharmacological problem: dose calculation. Adult amoxicillin dosing is not pediatric dosing. Body weight matters for amoxicillin, doxycycline, and many other antibiotics. A 500 mg adult amoxicillin capsule given to a 25 kg child is potentially toxic dosing and almost certainly not therapeutic for the bacterial syndrome the parent assumed was present. The risk profile of person-to-person diversion is therefore worse than the risk profile of leftover-self-use; the dose-to-weight matching that the original prescription assumed has been broken.

Channel 3: Under-the-counter sales from local stores (6 studies, ~9,700 respondents)

Larson and Grullon-Figueroa's 2004 New York City survey documented that 34 bodegas, grocery stores, delicatessens, and botanical or health-food stores in Hispanic neighborhoods sold antibiotics without prescription. The medications offered included ampicillin, tetracycline, erythromycin, and amoxicillin. Similar findings in Texas (Zoorob 2016), South Carolina (Mainous 2005), and Florida (Sanchez 2014). The channel operates through ethnic markets that obtain product from international sources where prescription requirements differ or are not enforced.

The operator-grade implication: this is the same regulatory pathway that the "fish antibiotics for humans" advocates relied on before the 2023 FDA Guidance for Industry #263 closed that channel (see Field Brief 03). The under-the-counter channel still exists for human pharmaceuticals in specific geographic and demographic contexts. It is not the operator-grade pathway because the product quality, dose verification, and indication appropriateness are all unverified.

Channel 4: Internet vendors (1 study)

Mainous and colleagues' 2009 study identified 138 internet vendors selling antibiotics without prescription to U.S. buyers. The product quality, regulatory provenance, and supply-chain integrity of these channels are not externally verified. International regulatory enforcement actions have repeatedly identified internet pharmacy channels as sources of counterfeit pharmaceuticals — wrong active ingredient, wrong dose, contamination, falsified labeling.

Channel 5: Veterinary sources (2 studies, ~400 respondents)

Goff and colleagues documented pet superstore sales of antibiotics without prescription, and Sanchez documented this channel in the Latino migrant worker population. The 2023 FDA Guidance for Industry #263 closed the major OTC pathway for medically important veterinary antimicrobials, including amoxicillin and similar agents (see Field Brief 03). However, the veterinary-source channel persists for products outside the FDA's recategorization scope, and for products obtained before the rule change. The operator-grade case against this channel was made in detail in Field Brief 03; the epidemiologic context here is that this channel is documented to have been a real source of nonprescription antibiotic supply for a measurable fraction of the U.S. population.

Channel 6: Other countries (multiple studies)

Cross-border supply through travel, immigration, and family connections. The Mainous 2005 South Carolina survey documented that 19 percent of Latino patients had transported nonprescription antibiotics from Latin American countries; the Larson 2006 New York City focus groups documented similar patterns. The mechanism is straightforward: in many Latin American, southern European, eastern European, and South Asian countries, antibiotics are legally available over-the-counter or with minimal regulatory friction. Travelers and immigrants bring product back to the U.S., where it enters informal supply networks.

Section 03The Antibiotics Most Often Diverted

Only two studies in the Grigoryan review specifically characterized which antibiotics circulate in the nonprescription channels. The findings are clinically informative.

Larson 2004 (New York City stores)

The under-the-counter inventory at surveyed stores included ampicillin, tetracycline, erythromycin, and amoxicillin. These are older first-generation antibiotics — the formulations that have been around long enough to have well-established international supply chains, low cost, and broad bacterial-spectrum claims that make them attractive to nonprescription buyers.

Zoorob 2016 (Texas primary care)

The most commonly reported antibiotics for nonprescription use, in descending order: amoxicillin (most common), azithromycin, ciprofloxacin, ampicillin, trimethoprim-sulfamethoxazole, tetracycline, ofloxacin, and amoxicillin-clavulanate. This list captures the modern outpatient antibiotic stack — the same drugs that account for most legitimate outpatient prescriptions are also the most-diverted drugs. The diversion follows the prescription pattern.

Symptom triggers

Three studies documented the symptoms most commonly cited as triggering nonprescription antibiotic use: sore throat, cough, earache, common cold, and painful urination. Four of those five conditions are most commonly viral — sore throat (predominantly viral pharyngitis), cough (predominantly viral bronchitis), earache (mixed etiology with substantial viral contribution), common cold (definitionally viral). Only painful urination has a high baseline probability of bacterial etiology (UTI). The implication: nonprescription antibiotic use is heavily directed at conditions where antibiotics are not indicated, which means most of the prescribed-dose-equivalent exposure is selecting resistance without conferring therapeutic benefit.

Section 04The Driver Variables — Why People Self-Medicate

Grigoryan identified ten distinct factors influencing nonprescription antibiotic use across the qualitative studies. Most cluster into three structural categories.

Access barriers

• Lack of health insurance or healthcare access: The single most-documented driver across populations. Patients without insurance or with high-deductible plans calculate that the out-of-pocket cost of a clinical visit plus a prescription exceeds the perceived benefit relative to using available leftover or under-the-counter medication.
• Cost of physician visits and prescription antibiotics: Documented across multiple Latino-population studies and injection drug user studies. The economic calculation is consistent: clinical visit costs $100-300, antibiotic costs $10-50, total $110-350. Under-the-counter or leftover supply costs $0-15. For symptoms the patient believes they recognize, the cost differential drives the channel choice.
• Transportation barriers: Particularly documented in migrant worker populations (Horton 2012, Sanchez 2014). Patients without reliable transportation to clinics, or in geographic areas without nearby clinics, default to whatever pharmaceutical supply is locally accessible.
• Long waiting periods in clinics: Patients who calculate they will wait 2-6 hours for a clinical encounter that produces a prescription they could have used immediately if they had their own supply.

Occupational and social factors

• Job preservation and income protection: Mexican migrant farm workers in Horton's 2012 study cited fear of losing job or missing a day's pay as primary drivers — taking time off work for a clinical visit is economically unviable. The same pattern in low-wage hourly workers across multiple populations.
• Fear of deportation: Documented in Latino migrant worker populations as a major barrier to engaging with the formal healthcare system, regardless of insurance status or cost.
• Embarrassment about seeking care for stigmatized conditions: Documented in the McDonald 2001 STI clinic and county jail population — patients reluctant to disclose symptoms suggestive of sexually transmitted infection to clinical providers, opting for nonprescription antibiotic self-treatment instead.
• Concerns about being mistreated or judged by healthcare providers: Particularly documented in injection drug user populations (Starrels 2009, Harris 2018). The clinical encounter is experienced as stigmatizing or punitive, driving avoidance.

Knowledge and belief factors

• Previous response to antibiotic treatment: Patients who believe they recognize their current symptoms as matching a previous condition that responded to a specific antibiotic reason that the same drug will work again. The clinical reality is that symptom-pattern recognition is unreliable — many bacterial conditions look like many viral conditions look like many non-infectious conditions. But the belief drives the practice.
• Relatives or friends provide antibiotics: The social network supplies the medication, and the social-network member who provides it implicitly validates its appropriateness. Diversion through social networks normalizes the practice.

The intervention failure pattern

Grigoryan documented one published intervention attempt — a mass media campaign in a South Carolina Latino community (Mainous 2009). The intervention failed. The percentage of respondents reporting nonprescription antibiotic use in the United States actually increased from 19 percent pre-intervention to 31 percent post-intervention. The authors hypothesized that the campaign may have inadvertently raised awareness of the channel rather than reducing use of it. The doctrinal implication for operators: this is not a problem that resolves with public education campaigns; the structural drivers (cost, access, time, fear, stigma) drive the practice regardless of awareness of the risks.

Section 05The Public Health Consequences

Nonprescription antibiotic use has three categories of documented harm.

Antimicrobial resistance

Treatment costs for antibiotic-resistant infections have doubled since 2002 and now exceed $2 billion annually in the U.S. (Thorpe 2018). The mechanism: subtherapeutic antibiotic dosing — taking the wrong drug, taking the right drug at the wrong dose, taking the right drug for too short a course, taking the right drug for the wrong indication — selects for bacterial populations capable of surviving the antibiotic. Each course of misused antibiotic is a small contribution to the population-level resistance pool. Multiply by the documented prevalence (millions of Americans annually using nonprescription antibiotics), and the public-health math is significant.

The international comparison reinforces the mechanism. Bryce and colleagues' 2016 meta-analysis of pediatric urinary tract infection antibiotic resistance documented that countries with widely available over-the-counter antibiotic sales had higher prevalence of antibiotic-resistant E. coli in pediatric UTIs. The causal direction is well-established: nonprescription use drives community-level resistance, which then constrains the antibiotic options available for serious infections.

Individual-level adverse drug events

Antibiotics accounted for 19 percent of all U.S. emergency department visits for adverse drug events in the Shehab 2008 surveillance data — roughly one in five drug-related ED visits. The mechanism categories: allergic reactions (the largest single category), drug-drug interactions, gastrointestinal toxicity (notably Clostridioides difficile infection, which is itself a documented complication of broad-spectrum antibiotic use), and direct organ toxicity for specific drug-patient combinations.

Nonprescription use elevates these risks because the prescribing safety net is absent. A clinical encounter screens for allergy history, current medications, contraindications, dose-appropriate-to-weight, indication appropriateness, and renal/hepatic function. Self-prescribing patients screen for none of these. The combination of unscreened use and high baseline ED-visit rate for antibiotic adverse events means nonprescription use measurably contributes to that ED-visit volume.

Masked underlying infections and delayed care

An antibiotic given for the wrong indication does not treat the actual condition. A patient with viral pharyngitis who takes amoxicillin for "strep throat" symptoms gets no benefit (the antibiotic does not act on the viral pathogen) but may experience partial symptomatic relief from the natural course of the viral illness — and may attribute that relief to the antibiotic, reinforcing the diversion pattern. A patient with appendicitis who attributes abdominal pain to "stomach flu" and self-medicates with antibiotics may delay surgical intervention until perforation occurs. A patient with bacterial meningitis who self-medicates with leftover antibiotics may receive insufficient dosing to clear the central nervous system infection while masking the fever and headache that would otherwise prompt emergency evaluation.

The Grigoryan review specifically notes the masked-infection risk and the disruption of healthy microbiome that broad-spectrum self-prescribing produces. Both are documented and both compound the antimicrobial resistance problem.

Section 06Why This Reframes the Operator-Grade Doctrine

The operator-grade antibiotic doctrine in Field Brief 01 recommended licensed prescriber sourcing, narrow indication discipline, weight-based dosing, full-course completion, and conservative species selection. The Grigoryan epidemiology reinforces every element of that doctrine and adds a population-level dimension the original brief did not emphasize.

The operator stockpile is not separate from the public-health context

The household that obtains amoxicillin through licensed prescriber pathway, stores it correctly per Field Brief 07, uses it only for documented indications, and completes appropriate full courses contributes nothing to community-level antimicrobial resistance. The household that obtains amoxicillin through under-the-counter or diversion channels, uses it for viral upper respiratory infections in adults and children, stops the course when symptoms improve, and shares leftovers across household members and acquaintances contributes meaningfully to community-level resistance. Both households think of themselves as "prepared." Only one is operating in a way that does not externalize cost onto the broader population.

The driver variables apply to operator households too

The cost, access, time, and convenience pressures that Grigoryan documents as driving nonprescription use in surveyed populations are not unique to those populations. The operator household facing $200 of out-of-pocket cost for an urgent care visit for a child's earache, in an evening when no pediatric clinic is open, makes the same calculation everyone else makes. The structural pull toward leftover-or-diversion use is universal; only the choice to maintain doctrinal discipline distinguishes operator-grade practice from the general pattern. The pull is real; the discipline has to be deliberate.

What the operator-grade alternative looks like in practice

• Pre-established clinical relationship. Every household member has a documented primary care provider; the household has a written list of clinic phone numbers, after-hours lines, and urgent care addresses. The first response to symptoms is engagement with the system, not engagement with the medicine cabinet.
• Documented telehealth pathway. Modern telehealth services (the major insurers, employer-sponsored programs, and direct-pay platforms) provide rapid clinical evaluation for the symptoms that most often drive nonprescription antibiotic use — sore throat, earache, urinary symptoms, sinus complaints. A 30-minute telehealth visit with appropriate antibiotic prescription where indicated costs less than most under-the-counter purchases and provides the screening that nonprescription use lacks.
• Stockpile via prescriber pathway, not via diversion or leftover accumulation. The operator who maintains a small stockpile of narrow-spectrum antibiotics for documented contingency-care scenarios works with their clinician to establish that stockpile through legitimate prescription pathway, with documented indications and dosing instructions. See Field Brief 01 for the framework.
• Discipline against leftover hoarding. Prescribed courses are completed; the prescription is not retained as future-use stockpile. This breaks the most-documented channel in the Grigoryan data.
• No diversion. Antibiotics prescribed for one household member are not given to other household members. The dose-to-weight matching and indication appropriateness do not survive the transfer.
• Active resistance to social-network sharing. When a relative or friend asks for leftover antibiotics, the operator declines and refers to clinical evaluation. The refusal is the operator-grade practice.

Section 07The Series Synthesis — Eight Briefs, One Doctrine

This is the closing brief of the Prepper & Survival Med series. The eight briefs together form a coherent operator-grade doctrine for household readiness across the medical dimension. The synthesis:

• Field Brief 01 — Survival Antibiotics: Licensed prescriber sourcing, narrow indication discipline, four core agents (amoxicillin, doxycycline, azithromycin, ciprofloxacin), weight-based dosing, full-course completion.
• Field Brief 02 — The Dental Abscess Trap: Why dental infection is the most-overlooked household medical emergency, dental kit doctrine, when antibiotics buy time and when they don't.
• Field Brief 03 — Animal and Fish Antibiotics for Humans: The 2023 FDA Guidance for Industry #263 regulatory collapse of the OTC channel, the published case-series harm data, why the practice is not operator-grade.
• Field Brief 04 — Medicine Cabinet Pharmacology Rebuild: Item-by-item audit of the standard 20-piece prepper medicine cabinet, validate-modify-rebut framework for every item.
• Field Brief 05 — Operator-Grade Medical Kit: CoTCCC MARCH framework, kit tiering from pocket through MCI, CoTCCC-recommended component sourcing (CAT GEN 7, QuikClot Combat Gauze, Chitogauze XR, Celox Rapid, Celox A, Persys Safeguard, Hyfin Vent).
• Field Brief 06 — Seven Areas First Aid Rebuilt: Modern doctrine across wounds, burns, fractures, poisoning, environmental, medical emergencies, shock, and behavioral health (the rebuilt eighth area).
• Field Brief 07 — Shelf Stability and SLEP: What expiration dates actually mean, SLEP data, four-tier rotation doctrine, what extends vs what doesn't.
• Field Brief 08 — Nonprescription Antibiotic Epidemiology (this brief): The population-level context, the documented source channels, why operator-grade doctrine matters at scale.

The unifying principle across all eight: doctrine, not slogans. The prepper-media landscape is rich in confident framings, easy heuristics, and bumper-sticker certainty. The published medical literature, the regulatory framework, and the clinical doctrine are richer in evidence, mechanism, and case-by-case judgment. The household that operates on doctrine is operationally different from the household that operates on slogans, and that difference compounds across the categories the series covers.

Section 08Bottom Line for the Operator

Seven principles, distilled from this brief and the series:

1. Nonprescription antibiotic use is current and prevalent practice, not a future hypothetical. Between 1 percent and 66 percent of U.S. populations report it, depending on subgroup. Storage prevalence is 14-48 percent. Intent prevalence is 25 percent. The numbers are not abstract.
2. Six documented source channels supply nonprescription antibiotics: leftover prescriptions, family/friend diversion, under-the-counter sales, internet vendors, veterinary sources, and cross-border supply. None of these are operator-grade pathways.
3. The drugs most diverted are the drugs most legitimately prescribed. Amoxicillin, azithromycin, ciprofloxacin, and the rest of the modern outpatient stack circulate in the nonprescription channels because they circulate in the prescription channels. The clinical familiarity that makes them appropriate also makes them divertable.
4. The symptoms triggering nonprescription use are mostly viral. Sore throat, cough, earache, common cold — antibiotics are not indicated for any of these in the vast majority of presentations. Most of the dose exposure produces no clinical benefit and contributes to resistance.
5. The driver variables are structural: cost, access, time, fear, stigma. Public-education campaigns do not solve the problem; one documented intervention attempt actually increased the practice. The structural drivers require structural responses (insurance access, telehealth availability, low-friction clinical engagement) — and individual responses require deliberate doctrinal discipline against the universal pull.
6. The operator-grade doctrine reinforces every element of the series: licensed prescriber sourcing, narrow indication, weight-based dosing, course completion, no diversion, no leftover hoarding, active refusal to share. The household that operates this way is in a structurally different position from the household that doesn't.
7. This is the closing brief of the series, but the series is the start, not the finish. The eight briefs together provide a doctrinal framework for household medical readiness across antibiotics, dental care, medicine cabinet, equipment, first aid, shelf stability, and the public-health context. The framework requires ongoing application: clinical relationships, training, kit rotation, doctrinal discipline. The framework is not a substitute for those activities; it is the structure they organize around.

That's the brief. That's the series.

ReferenceFrequently Asked Questions